ReviewOncology reports2021

Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).

Emily L Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.